laseraway semaglutide results are in! 👏🏼😍 Our beautiful patient just completed 3 months of our medically supervised weight loss program. Over the last 90 days she has continued to exercise and eat a Semaglutide in Houston, TX -

McGeer PL

They exhibit multiple cellular pathways for repair, supporting the immune response, and maintaining overall health

Squeeze sachet into a shot glass amount of water or juice

Address facial volume changes with fillers, boosters, or collagen therapies

Eli Lilly and Company Novo Nordisk #Pharma #GLP1 #Biologics #PharmaSupplyChain #DrugSafety Biotech Executive, Thought Leader & Creator | Diagnostics Executive | Microfluidics & Immunoassay Innovation | FDA Strategy Led EUA 230055, EUA 240006 & 510(k) K240728 | Oncology, AIBiology & IVD Commercialization Eli Lilly and Company #Retatrutide Phase 3 #Breakthrough: #Triple #Agonist (GLP-1/GIP/Glucagon) Driving Fat Burn, Appetite Control & Glucose Regulation Shows Up to 2.0% A1C Reduction + ~17% Weight Loss A major milestone in cardiometabolic innovation: Eli Lilly and Companys #retatrutide (GIP + GLP-1 + glucagon triple agonist) delivers best-in-class efficacy signals in Phase 3 (TRANSCEND-T2D-1) Key results (40 weeks) 1 Glycemic control A1C reduction: -1.7% to -2.0% vs placebo: -0.8% 2 Weight loss Up to -16.8% (~36.6 lbs) No plateau weight loss still ongoing 3 Cardiometabolic benefits Improvements in lipids, triglycerides, and blood pressure Key voice: Kenneth Custer Ph.D